Oncotelic Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-11.
Oncotelic Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 11, 2025. The filing reports $275K sold. Its industry group is Biotechnology. It names VUONG TRIEU (Executive Officer, Director) (SEC Form D, December 11, 2025).
Sell to companies like Oncotelic Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Oncotelic Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Oncotelic Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in December 2025, largest first.
Get an email when Oncotelic Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Oncotelic Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Oncotelic Therapeutics, Inc. →Get the full cited report on Oncotelic Therapeutics, Inc.
What the filing shows about Oncotelic Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Oncotelic Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Oncotelic Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Oncotelic Therapeutics, Inc. See pricing
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $275K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Assuming all $12.5 million is raised and J.H. Darbie & Co earns 15% commission
Vuong Trieu is named as Executive Officer and Director on the Form D that Oncotelic Therapeutics, Inc. filed with the SEC on 11 December 2025, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2025-12-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Oncotelic Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Oncotelic Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Oncotelic Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Oncotelic Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Oncotelic Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Oncotelic Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/oncotelic-therapeutics-inc-form-d-25000001